Skip to main content
Log in

Lymphadenopathy in systemic lupus erythematosus. Prevalence and relation to disease manifestations

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

Lymphadenopathy (LAP) is a frequent sign in systemic lupus erythematosus (SLE). Yet, data concerning its relation to the various disease manifestations are scarce or absent. LAP was present in 23/90 (26%) SLE patients. Patients with LAP had significantly more constitutional symptoms of fatigue, fever and weight loss, more cutaneous symptoms and signs, a higher rate of hepatomegaly and splenomegaly, increased anti-dsDNA antibodies and decreased complement levels. Disease activity index was higher among patients with LAP, as was the intake of steroids and antimalaria medications. There was no difference in renal or central nervous system (CNS) involvement between patients with LAP and those without LAP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tan, E.M., Cohen, A.S., Fries, J.F. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25, 1271–1277.

    PubMed  Google Scholar 

  2. Symmons, D.P.M., Coppock, J.S., Bacon, P.A. et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus (Appendix 2). Quart J Med 1988, 69, 927–937.

    PubMed  Google Scholar 

  3. Harvey, A.M., Shulman, L.E., Tumulty, P.A., Conley, C.L., Schoenrich, E.H. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954, 33, 291–437.

    Google Scholar 

  4. Jessar, R.A., Lamart-Havers, R.W., Regan, C. Natural history of lupus erythematosus disseminatus. Ann Intern Med 1953, 38, 717–731.

    PubMed  Google Scholar 

  5. Fries, J.F., Holman, H.R. Systemic lupus erythematosus: a clinical analysis. Major Probl Intern Med 1975, 6, V-199.

    PubMed  Google Scholar 

  6. Dubois, E.L., Tuffanelli, D.L. Clinical manifestations of systemic lupus erythematosus - computer analysis of 520 cases. JAMA 1964, 190, 104–111.

    PubMed  Google Scholar 

  7. Estes, D., Christian, C.L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971, 50, 85–95.

    Google Scholar 

  8. Fox, R.A., Rosahn, P.D. Lymph nodes in disseminated lupus erythematosus. Am J Pathol 1943, 19, 73–99.

    Google Scholar 

  9. Pistiner, M., Wallace, D.J., Nessim, S., Metzger, A.L., Kleinenberg, J.R. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arth Rheumat 1991, 21, 55–64.

    Google Scholar 

  10. Lockshin, M.D., Reinitz, E., Druzin, M.L., Murrman, M., Estes, D. Lupus pregnancy. Case control prospective study demonstrating absence of lupus exacerbrations during or after pregnancy. Am J Med 1984, 77, 893–898.

    PubMed  Google Scholar 

  11. Dillon, C.E., Jones, J.V., Reichlin, M. Antibody to Ro in a population of patients with systemic lupus erythematosus: distribution, clinical and serologic associations. J Rheum 1983, 10, 380–6.

    PubMed  Google Scholar 

  12. Liang, M.H., Socher, S.A., Larson, M.G., Schur, P.H. Reliability and validity of six systems for the clinical assessment of disease activity of systemic lupus erythematosus. Arthritis Rheum 1989, 32, 1107–1118.

    PubMed  Google Scholar 

  13. Committee on prognosis studies in SLE: Prognosis studies in SLE: an activity index. Arthritis Rheum 1986, 29 suppl 4, S93.

  14. Urowitz, M.B., Gladman, D.D., Tozman, E.C.S., Goldsmith, C.H. The lupus activity criteria count (LACC). J Rheumatol 1984, 11, 783–787.

    PubMed  Google Scholar 

  15. Morimoto, C., Sano, H., Abe, T., Homma, M., Steinberg, A.D. Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes. J Immunol 1982, 129, 1960–1966.

    PubMed  Google Scholar 

  16. Isenberg, D.A., Morrow, W.J.W., Snaith, M.L. Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus. Ann Rheum Dis 1982, 41, 347–351.

    PubMed  Google Scholar 

  17. Ward, M.H., Polisson, R.P. A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus. Arthritis Rheum 1989, 32, 1226–1232.

    PubMed  Google Scholar 

  18. King, K.K., Kornreich, H.K., Bernstein, B.H., Singsen, B.H., Hanson, V. The clinical spectrum of systemic lupus erythematosus in childhood. Arthritis Rheum 1977, 20, 287.

    PubMed  Google Scholar 

  19. Schur, P.H. Clinical features of SLE. In: Textbook of Rheumatology. Eds.: Kelly, W.N., Harris, E.D., Jr., Ruddy, S., Sledge, C.B. Philadelphia, WB Saunders, 1989, 1111.

    Google Scholar 

  20. Rothfield, N.F. Systemic lupus erythematosus: clinical aspects and treatment. In: Arthritis and Allied Conditions. Ed.: McCartey, D.J., Philadelphia, Lea & Febiger. 1989, 1038.

    Google Scholar 

  21. Smolen, J.S., Chused, T.M., Leiserson, W.M., Reeves, J.P., Alling, D., Steinberg, A.D. Heterogenicity of immunoregulatory Tcells subsets in systemic lupus erythematosus. Am J Med 1982, 72, 783–790.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shapira, Y., Weinberger, A. & Wysenbeek, A.J. Lymphadenopathy in systemic lupus erythematosus. Prevalence and relation to disease manifestations. Clin Rheumatol 15, 335–338 (1996). https://doi.org/10.1007/BF02230354

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02230354

Key words

Navigation